These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 2440519)

  • 1. Lesioning and recovery of the serotoninergic projections to the hippocampus.
    Lombardi G; Gandolfi O; Dall'Olio R; Pellegrini-Giampietro DE; Beni M; Carla V; Consolazione A; Moroni F
    Brain Res; 1987 May; 411(2):275-81. PubMed ID: 2440519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lesioning and recovery of the serotoninergic hippocampal afferents: differential effects of GM1 ganglioside.
    Lombardi G; Beni M; Consolazione A; Moroni F
    Neuropharmacology; 1988 Nov; 27(11):1085-8. PubMed ID: 2462696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [3H]paroxetine binding and serotonin content of rat and rabbit cortical areas, hippocampus, neostriatum, ventral mesencephalic tegmentum, and midbrain raphe nuclei region.
    Dewar KM; Reader TA; Grondin L; Descarries L
    Synapse; 1991 Sep; 9(1):14-26. PubMed ID: 1724575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of grafts containing cholinergic and/or serotonergic neurons on cholinergic, serotonergic and noradrenergic markers in the denervated rat hippocampus.
    Cassel JC; Neufang B; Kelche C; Jeltsch H; Will BE; Hertting G; Jackisch R
    Brain Res; 1993 Feb; 604(1-2):53-63. PubMed ID: 7681347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The distribution of serotonergic 5-HT1A and non-5-HT1A recognition sites along the dorso-ventral axis of the rat hippocampus.
    Kiedrowski L
    Pol J Pharmacol Pharm; 1991; 43(2):103-13. PubMed ID: 1946036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in the regulatory adaptation of the 5HT recognition sites labelled by 3H-mianserin or 3H-ketanserin.
    Barbaccia ML; Gandolfi O; Chuang DM; Costa E
    Neuropharmacology; 1983 Jan; 22(1):123-6. PubMed ID: 6843781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-related changes in rat serotonergic and adrenergic systems and in receptor responsiveness to subchronic desipramine treatment.
    Brunello N; Riva M; Rovescalli AC; Galimberti R; Racagni G
    Pharmacol Toxicol; 1988 Sep; 63(3):150-5. PubMed ID: 2460847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of different photoperiod exposure on [3H]imipramine binding and serotonin uptake in the rat brain.
    Rovescalli AC; Brunello N; Riva M; Galimberti R; Racagni G
    J Neurochem; 1989 Feb; 52(2):507-14. PubMed ID: 2463336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of carbon monoxide exposure on serotonergic neuronal systems in rat brain.
    Muraoka M; Hayakawa H; Kagaya A; Kojima T; Yamawaki S
    Life Sci; 1998; 62(23):2101-8. PubMed ID: 9627089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High and low affinity 5-HT2 and 5-HT1C binding sites: responses to neonatal 5,7-DHT lesions in rat brain.
    Pranzatelli MR; Gregory CM
    Cytobios; 1993; 75(302-303):197-209. PubMed ID: 8243108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenergic regulation of [3H]ketanserin binding sites during immobilization stress in the rat frontal cortex.
    Torda T; Murgas K; Cechova E; Kiss A; Saavedra JM
    Brain Res; 1990 Sep; 527(2):198-203. PubMed ID: 1701336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of imipramine on central 5-hydroxytryptamine turnover and metabolism in rats.
    Segawa T; Mizuta T
    Jpn J Pharmacol; 1980 Dec; 30(6):789-93. PubMed ID: 6165851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of serotonergic denervation on the density and plasticity of brain muscarinic receptors in the rat.
    Alonso R; Soubrie P
    Synapse; 1991 May; 8(1):30-7. PubMed ID: 1714634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of the putative anxiolytic TVX Q 7821 to hippocampal 5-hydroxytryptamine (5-HT) recognition sites.
    Glaser T; Traber J
    Naunyn Schmiedebergs Arch Pharmacol; 1985 May; 329(3):211-5. PubMed ID: 3160954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Destruction of the nucleus raphe obscurus and potentiation of serotonin-mediated behaviors following administration of the neurotoxin 3-acetylpyridine.
    Wieland S; Kreider MS; McGonigle P; Lucki I
    Brain Res; 1990 Jun; 520(1-2):291-302. PubMed ID: 1698505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin (5-HT) release in the dorsal raphé and ventral hippocampus: raphé control of somatodendritic and terminal 5-HT release.
    Matos FF; Urban C; Yocca FD
    J Neural Transm (Vienna); 1996; 103(1-2):173-90. PubMed ID: 9026372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin uptake sites and serotonin receptors are altered in the limbic system of schizophrenics.
    Joyce JN; Shane A; Lexow N; Winokur A; Casanova MF; Kleinman JE
    Neuropsychopharmacology; 1993 Jun; 8(4):315-36. PubMed ID: 8512620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of methiothepin on imipramine- or mianserin- induced subsensitivity of serotonergic receptors.
    Segawa T; Uehara M
    Life Sci; 1982 Mar; 30(10):809-12. PubMed ID: 7070196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different effects of serotonin antagonists on 3H-mianserin and 3H-ketanserin recognition sites.
    Gandolfi O; Barbaccia ML; Costa E
    Life Sci; 1985 Feb; 36(8):713-21. PubMed ID: 2983168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-site model of the neuronal 5-hydroxytryptamine uptake and imipramine-binding site.
    Marcusson JO; Bäckström IT; Ross SB
    Mol Pharmacol; 1986 Aug; 30(2):121-8. PubMed ID: 3016498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.